These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17929545)

  • 1. [Antifungal drug resistance: mechanisms of resistance, freqeuncy, prevention and control of resistance].
    Mitrović SM; Dzamić AM; Arsić-Arsenijević VS; Radonjić IV; Kranjcić-Zec IF
    Srp Arh Celok Lek; 2007; 135(7-8):486-94. PubMed ID: 17929545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.
    Kanafani ZA; Perfect JR
    Clin Infect Dis; 2008 Jan; 46(1):120-8. PubMed ID: 18171227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antifungal susceptibility testing in patient management.
    Forrest G
    Curr Opin Infect Dis; 2006 Dec; 19(6):538-43. PubMed ID: 17075328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibility testing in fungi: a global perspective on a variety of methods.
    Lass-Flörl C; Perkhofer S; Mayr A
    Mycoses; 2010 Jan; 53(1):1-11. PubMed ID: 20078786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal drug resistance of pathogenic fungi.
    Kontoyiannis DP; Lewis RE
    Lancet; 2002 Mar; 359(9312):1135-44. PubMed ID: 11943280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of resistance to antifungals.
    Rodriguez-Tudela JL; Alcazar-Fuoli L; Cuesta I; Alastruey-Izquierdo A; Monzon A; Mellado E; Cuenca-Estrella M
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S111-3. PubMed ID: 19013333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mycoses].
    Yamazumi T; Furuta I
    Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of disk diffusion test and Etest for voriconazole and fluconazole susceptibility testing.
    Buchta V; Vejsova M; Vale-Silva LA
    Folia Microbiol (Praha); 2008; 53(2):153-60. PubMed ID: 18837162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of antifungal resistance and its impact on clinical practice.
    Alcazar-Fuoli L; Mellado E
    Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fungal blood stream infection, its pathogen and antifungal susceptibility in cancer patients].
    Fujihara S; Imataki O; Tamai Y; Kawakami K
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2383-7. PubMed ID: 19098407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility testing: a primer for clinicians.
    Kuper KM; Coyle EA; Wanger A
    Pharmacotherapy; 2012 Dec; 32(12):1112-22. PubMed ID: 23165897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing epidemiology of systemic fungal infections.
    Richardson M; Lass-Flörl C
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
    Cuenca-Estrella M; Gomez-Lopez A; Gutierrez MO; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1062-5. PubMed ID: 18195057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal combinations.
    Vitale RG; Afeltra J; Dannaoui E
    Methods Mol Med; 2005; 118():143-52. PubMed ID: 15888940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues in antifungal susceptibility testing.
    Johnson EM
    J Antimicrob Chemother; 2008 Jan; 61 Suppl 1():i13-8. PubMed ID: 18063599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug resistance in the treatment of invasive fungal infections].
    Nordøy I; Gaustad P
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2607-11. PubMed ID: 19023376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Determining the susceptibility of microfungi to antifungals and interpreting the results].
    Mallátová N
    Klin Mikrobiol Infekc Lek; 2007 Aug; 13(4):150-5. PubMed ID: 17929220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.
    Sanglard D; Coste A; Ferrari S
    FEMS Yeast Res; 2009 Oct; 9(7):1029-50. PubMed ID: 19799636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of Mexican isolates of yeasts and moulds to amphotericin B and triazole antifungals.
    Arredondo-García JL; Amábile-Cuevas CF;
    J Infect Dev Ctries; 2009 Jun; 3(5):398-401. PubMed ID: 19759511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance.
    Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP
    Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.